首页 > 市场调查报告书 > 材料

有机化合物

市场调查报告书

商品编码

1512688

全球磷脂质市场 - 2024-2031

Global Phospholipids Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 243 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年全球磷脂市场规模达29.7亿美元，预计2031年将达到51.3亿美元，2024-2031年预测期间复合年增长率为7.03%。

磷脂因其独特的性质和功能而成为具有多种应用的重要成分。它们可以来自大豆、向日葵、鸡蛋等，并且有多种类型，包括磷脂酰丝氨酸和磷脂酰胆碱。磷脂因其各种促进健康的特性而受到认可，包括心血管健康、认知功能支持和皮肤健康改善。

磷脂具有一系列功能，因此可应用于各个行业，包括食品和饮料、营养补充剂和药品，以及其他领域的其他应用。消费者意识的不断增强正在推动多个行业采用磷脂质并促进市场成长。

北美主导全球市场。该地区患有心臟病和糖尿病等慢性疾病。根据美国疾病管制与预防中心的数据，2021 年美国有8.9% 的人口被诊断出患有糖尿病此外，2021 年美国约有695,000 人死于心臟病。中发挥着至关重要的作用并提高生物利用度，推动其在区域市场的需求。

动力学

製药和保健品产业对磷脂质的需求不断增长

随着心臟病和糖尿病等慢性疾病变得越来越普遍，对有效治疗的需求也增加。人们对保持身体健康和创造营养保健品和药品市场更感兴趣。人们对预防性医疗保健的日益关注刺激了对含有磷脂的药物和营养产品的需求，磷脂被认为对整体健康有益。

磷脂有助于药物更好地被人体吸收，使其更有效。许多药物难溶于水。磷脂不能很好地固定某些药物的溶解度，从而实现更好的递送。随着製药和营养保健品产业在全球范围内不断扩张，对磷脂质的需求预计将大幅成长。

新品发布

引入市场的新产品和技术增加了磷脂在各种最终用途应用中的探索和利用，并提供了新的和可用的实用选项，扩大了市场成长。例如，2024年5月，Vitafoods Europe推出了MPL+，这是一种海洋磷脂细胞营养和创新产品。 MPL+ 技术平台利用磷脂质作为独特输送平台的潜力，为营养保健品产业带来创新。

同样，2022年11月，Aker BioMarine推出了新的PL+技术平台，利用磷虾中的磷脂来提高生物利用度或吸收率较差的成分的溶解度和乳化性。 PL+ 技术封装在软凝胶中，其中含有大麻二酚、姜黄素等具有挑战性的成分。根据 Aker BioMarine 的说法，PL+ 可以将吸收提高多达 25 倍。

与磷脂相关的高成本

全球磷脂市场的主要阻碍因素之一是生产和提取过程的高成本。磷脂质并不容易从大豆或鸡蛋等天然来源中取得。这些复杂的萃取技术需要昂贵的设备、先进的技术和熟练的劳动力。高效提取依赖复杂的技术，从而增加了整体成本。

此外，原物料波动也会加剧价格上涨。大豆、鸡蛋或葵花籽（磷脂质的主要来源）的成本可能会发生显着变化。这种不稳定性使生产商难以预测和管理其整体定价。这可能会阻碍公司进入市场并限制消费者对磷脂质产品的承受能力。

Phospholipids are essential components with diverse applications due to their unique properties and functions. They can be sourced from soybeans, sunflowers, eggs and others and come in various types, including phosphatidylserine and phosphatidylcholine. Phospholipids are recognised for their various health-promoting properties, including cardiovascular health, cognitive function support and skin health improvement.

Phospholipids offer a range of functionalities, due to which they find applications in various industries including food and beverages, nutraceutical supplements, and pharmaceuticals with additional applications in other sectors. The growing consumer awareness is driving the adoption of phospholipids across multiple industries and contributing to market growth.

North America dominates the global market. The region struggles with a high prevalence of chronic diseases like heart disease and diabetes. According to the Centers for Disease Control and Prevention, 8.9% of US population was diagnosed with diabetes in 2021. Also, about 695,000 people in US died from heart disease in 2021. This necessitates effective treatments, and phospholipids play a crucial role in drug delivery and improving bioavailability, driving its demand in the regional market.

Dynamics

Growing Demand for Phospholipids in Pharmaceutical and Nutraceutical Industries

As chronic diseases like heart disease and diabetes become more prevalent, the demand for effective treatments increases. People are more interested in maintaining good health and creating a market for nutraceutical and pharmaceutical products. The growing focus on preventive healthcare fuels the demand for pharmaceutical and nutraceutical products containing phospholipids which are seen as beneficial for overall health.

Phospholipids help drugs get absorbed better by the body, making them more effective. Many drugs are poorly soluble in water. Phospholipids fix poorly the solubility of certain drugs allowing for better delivery. As the pharmaceutical and nutraceutical sectors continue to expand globally, the demand for phospholipids is expected to rise significantly.

New and Innovative Launches

The new products and technologies introduced into the market increase the exploration and utilisation of phospholipids in various end-use applications with new and accessible utility options, expanding the market growth. For instance, in May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.

Similarly, in November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates. The PL+ technology comes encapsulated in soft gels with challenging ingredients, such as cannabidiol, curcumin and others. According to Aker BioMarine, PL+ can boost absorption by up to 25 times.

High Costs Associated with Phospholipids

One major hindering factor for the global phospholipids market is the high cost associated with production and extraction processes. Phospholipids aren't easy to get from their natural sources like soybeans or eggs. These complex extraction techniques require expensive equipment, advanced technology and a skilled workforce. Efficient extraction relies on sophisticated technology, adding to the overall cost.

In addition, raw material fluctuations can also add fuel to the higher prices. The cost of soybeans, eggs, or sunflower seeds, the main sources of phospholipids, can change significantly. This instability makes it difficult for producers to predict and manage their overall pricing. This can discourage companies from entering the market and limit the affordability of phospholipid products for consumers.

Segment Analysis

The global phospholipids market is segmented based on type, source, functionality, application and region.

Rising Need for Functional Food and Beverage Products

The global phospholipids market is segmented based on application into food & beverage, nutraceutical supplements, pharmaceuticals and others. The food & beverage segment accounts for the largest share of the global market. The multifunctional properties of phospholipids, coupled with consumer demand for healthier, clean-label food and beverage products, contribute to the dominance of the food and beverage application segment in the global phospholipids market.

People are increasingly prioritizing healthy eating and functional foods that offer additional health benefits. With a growing emphasis on health and wellness, consumers are increasingly seeking out food and beverage products that offer functional benefits. Phospholipids play a crucial role in improving the texture and mouthfeel of food and beverage products.

In the food and beverage industry, phospholipids are widely used emulsifiers in products such as margarine, chocolate, dressings, and beverages to create stable emulsions, improve texture, and enhance mouthfeel. Phospholipids can be added to functional beverages to enhance nutrient delivery, improve stability, and impart health benefits, aligning with consumer preferences for functional and convenient beverage options.

Geographical Penetration

Greater Presence of Phospholipids Utilising Industries in North America

North America dominates the global market with the presence of various leading pharmaceutical and nutraceutical companies that heavily rely on phospholipids for various applications. These industries are at the forefront of research and development, driving demand for innovative phospholipid products. The region's well-established pharmaceutical industry utilizes phospholipids in drug delivery systems and formulations.

Additionally, the region has a robust food and beverage industry, where phospholipids are used as emulsifiers and functional ingredients in a wide range of products. The presence of key market players and research institutions focused on lipid science also contributes to the region's dominance. The region is benefited from the presence of advanced technology and skilled labor, which leads to efficient extraction and processing methods.

Competitive Landscape

The major global players in the market include Cargill, Inc., Archer Daniels Midland Company, Bunge Ltd, Lipoid GmbH, VAV Life Sciences, American Lecithin Company, Kewpie Corporation, Lecico GmbH, Nabros Pharma Pvt. Ltd., and Croda International Plc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global phospholipids market. During the initial phases of the pandemic, lockdowns, travel restrictions and disruptions in transportation networks led to challenges in the supply chain for raw materials and finished phospholipid products. This resulted in delays in production, procurement difficulties and increased logistics costs for manufacturers and suppliers.

The pandemic altered consumer behaviours and preferences, leading to changes in demand for phospholipid-containing products, due to an increased focus on health and wellness. There was increased demand for certain pharmaceutical formulations and functional foods with immune-boosting ingredients. The pharmaceutical and nutraceutical industries, which are significant consumers of phospholipids, experienced varying impacts, positively impacting the market growth.

By Type

Phosphotidylserine
Phosphotidylcholine
Others

By Source

Soy
Sunflower
Egg
Others

By Functionality

Emulsifying
Wetting & Dispersion
Thickening & Gelling
Nutrient Delivery

By Application

Food & beverage
Nutraceutical Supplements
Pharmaceuticals
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.
In November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates.
In January 2021, NZMP, a dairy ingredient-solutions brand by global dairy mainstay Fonterra, launched milk phospholipids. Naturally present in milk, these complex lipids are clinically proven to help manage the effects of stress, to allow consumers to stay focused and positive under stress.

Why Purchase the Report?

To visualize the global phospholipids market segmentation based on type, source, functionality, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of phospholipids market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global phospholipids market report would provide approximately 70 tables, 64 figures and 243 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Source
3.3. Snippet by Functionality
3.4. Snippet by Application
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Phospholipids in Pharmaceutical and Nutraceutical Industries
  - 4.1.1.2. New and Innovative Launches
- 4.1.2. Restraints
  - 4.1.2.1. High Costs Associated with Phospholipids
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Phosphotidylserine
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Phosphotidylcholine
7.4. Others

8. By Source

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 8.1.2. Market Attractiveness Index, By Source
8.2. Soy
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sunflower
8.4. Egg
8.5. Others

9. By Functionality

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 9.1.2. Market Attractiveness Index, By Functionality
9.2. Emulsifying
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Wetting & Dispersion
9.4. Thickening & Gelling
9.5. Nutrient Delivery

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Food & Beverage
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Nutraceutical Supplements
10.4. Pharmaceuticals
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Cargill, Inc.
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Archer Daniels Midland Company
13.3. Bunge Ltd.
13.4. Lipoid GmbH
13.5. VAV Life Sciences
13.6. American Lecithin Company
13.7. Kewpie Corporation
13.8. Lecico GmbH
13.9. Nabros Pharma Pvt. Ltd.
13.10. Croda International Plc.

LIST NOT EXHAUSTIVE